FDA.reportPublic FDA data

BILPREVDA 120 MG in 1.7 ML Injection

RxCUI
2723345
RxNorm name
BILPREVDA 120 MG in 1.7 ML Injection
Display name
BILPREVDA 120 MG in 1.7 ML Injection
Full name
BILPREVDA 120 MG in 1.7 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761444Bildyosdenosumab-nxxp351(k) InterchangeableRx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b1f0590e-f5bb-44ac-99a0-4aa4596c7e54BILPREVDA 120 MG in 1.7 ML Injection [PSN] · 1.7 ML denosumab-nxxp 70 MG/ML Injection [Bilprevda] [SBD] · Bilprevda 120 MG per 1.7 ML Injection [SY]32These highlights do not include all the information needed to use BILPREVDA safely and effectively. See full prescribing information for BILPREVDA. BILPREVDA ® (denosumab-nxxp) injection, for subcutaneous use Initial U.S. Approval: 2025 BILPREVDA ® (denosumab-nxxp) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differen20250910